1. Impurity testing of ranitidine products: US FDA update

   News item 16 November 2019 Pages: 1 - 1

2. Increased risk of CV-related death with febuxostat

   News item 16 November 2019 Pages: 2 - 2

3. PRAC completes reviews of alemtuzumab and tofacitinib

   Unknown 16 November 2019 Pages: 3 - 3

4. In utero paracetamol exposure increases risk of ADHD and autism

   Clinical study 16 November 2019 Pages: 4 - 4

5. Adverse pregnancy or infant outcomes with adalimumab

   Clinical study 16 November 2019 Pages: 5 - 5

6. Anticoagulant treatment failure after concomitant AEDs

   Clinical study 16 November 2019 Pages: 6 - 6

7. Effects of antiretrovirals on risk of hypertension during pregnancy

   Clinical study 16 November 2019 Pages: 7 - 7

8. Infliximab in pregnancy: no unexpected adverse events

   Clinical study 16 November 2019 Pages: 8 - 8

9. Many antibacterials associated with acute kidney injury

   Clinical study 16 November 2019 Pages: 9 - 9

10. PPI adverse events: knowledge and behaviour change survey

    Clinical study 16 November 2019 Pages: 10 - 10

11. Risk minimisation measures for fentanyl buccal tablets

    Clinical study 16 November 2019 Pages: 11 - 11

12. Second-generation antipsychotics: risk of pregnancy complications

    Clinical study 16 November 2019 Pages: 12 - 12

13. Abatacept

    Case report 16 November 2019 Pages: 13 - 13

14. Abatacept/tocilizumab

    Case report 16 November 2019 Pages: 14 - 14

15. Acenocoumarol/heparin

    Case report 16 November 2019 Pages: 15 - 15

16. Acetazolamide

    Case report 16 November 2019 Pages: 16 - 16

17. Actinium 225 DOTATATE

    Case report 16 November 2019 Pages: 17 - 17

18. Afatinib

    Case report 16 November 2019 Pages: 18 - 18

19. Amino acids mix/lutetium-(177lu)-oxodotreotide

    Case report 16 November 2019 Pages: 19 - 19

20. Amiodarone

    Case report 16 November 2019 Pages: 20 - 20

21. Amoxicillin

    Case report 16 November 2019 Pages: 21 - 21

22. Anaesthetics/sodium-bicarbonate

    Case report 16 November 2019 Pages: 22 - 22

23. Antidepressants

    Case report 16 November 2019 Pages: 23 - 23

24. Antidepressants/antipsychotics/methylphenidate

    Case report 16 November 2019 Pages: 24 - 24

25. Antifungals/rifampicin/prednisone

    Case report 16 November 2019 Pages: 25 - 25

26. Antineoplastics

    Case report 16 November 2019 Pages: 26 - 26

27. Antineoplastics

    Case report 16 November 2019 Pages: 27 - 27

28. Antineoplastics

    Case report 16 November 2019 Pages: 28 - 28

29. Antineoplastics

    Case report 16 November 2019 Pages: 29 - 29

30. Antineoplastics

    Case report 16 November 2019 Pages: 30 - 30

31. Antineoplastics

    Case report 16 November 2019 Pages: 31 - 31

32. Antineoplastics

    Case report 16 November 2019 Pages: 32 - 32

33. Antineoplastics

    Case report 16 November 2019 Pages: 33 - 33

34. Antineoplastics

    Case report 16 November 2019 Pages: 34 - 34

35. Antineoplastics

    Case report 16 November 2019 Pages: 35 - 35

36. Antineoplastics

    Case report 16 November 2019 Pages: 36 - 36

37. Antipsychotics

    Case report 16 November 2019 Pages: 37 - 37

38. Antipsychotics

    Case report 16 November 2019 Pages: 38 - 39

39. Antipsychotics/clonidine

    Case report 16 November 2019 Pages: 39 - 39

40. Antituberculars

    Case report 16 November 2019 Pages: 40 - 40

41. Aripiprazole

    Case report 16 November 2019 Pages: 41 - 41

42. Aspirin/clopidogrel

    Case report 16 November 2019 Pages: 42 - 42

43. Avelumab

    Case report 16 November 2019 Pages: 43 - 43

44. Axitinib/sunitinib

    Case report 16 November 2019 Pages: 44 - 44

45. BCG

    Case report 16 November 2019 Pages: 45 - 45

46. BCG

    Case report 16 November 2019 Pages: 46 - 46

47. BCG

    Case report 16 November 2019 Pages: 47 - 47

48. BCG-vaccine

    Case report 16 November 2019 Pages: 48 - 48

49. Betamethasone misuse

    Case report 16 November 2019 Pages: 49 - 49

50. Bevacizumab

    Case report 16 November 2019 Pages: 50 - 50